prof. dr. Xavier Verhelst
Show
Sort by
-
An unusual cause of portal hypertension
-
- Journal Article
- A1
- open access
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant
-
Patients hospitalized with alcohol-related liver disease and prior bariatric surgery are more prone to develop acute-on-chronic liver failure
-
- Journal Article
- A1
- open access
Meta-analysis : the impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease
-
- Journal Article
- A1
- open access
Impact on follow-up strategies in patients with primary sclerosing cholangitis
-
- Journal Article
- A1
- open access
Kupffer cells contested as early drivers in the pathogenesis of primary sclerosing cholangitis
-
Glycomics-based serum markers as reliable tool for assessment of viral response after treatment with direct-acting antiviral drugs in hepatitis C virus infection
-
Yttrium-90 radioembolization versus drug-eluting beads chemoembolization for unresectable hepatocellular carcinoma : results from the TRACE phase 2 randomized controlled trial
-
Neurometabolic and gliovascular changes in murine hepatic encephalopathy
-
Long-term obeticholic acid (OCA) for primary biliary cholangitis (PBC) in a clinical trial improved event free survival (death, liver transplant and hepatic decompensation) compared to external controls from the GLOBAL PBC real-world database